Steroid receptors and cell cycle in normal mammary epithelium

Journal of Mammary Gland Biology and Neoplasia

Volumn 9, Issue 1, 2004, Pages 3-13

  Anderson, Elizabeth ^a   Clarke, Robert B ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Cell cycle; Estrogen; Estrogen receptor; Mammary epithelium; Progesterone; Progesterone receptor

Indexed keywords

CYCLIN D; CYCLIN DEPENDENT KINASE; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GROWTH FACTOR; PROGESTERONE; PROGESTERONE RECEPTOR; PROGESTERONE RECEPTOR A; PROGESTERONE RECEPTOR B; PROTEIN P21; STEROID HORMONE; STEROID RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

BREAST CANCER; BREAST CARCINOGENESIS; BREAST DEVELOPMENT; BREAST EPITHELIUM; BREAST LESION; CELL CYCLE; CELL PROLIFERATION; EPITHELIUM CELL; EXPERIMENTATION; HUMAN; NONHUMAN; OVARY; PARACRINE SIGNALING; PRECANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW;

CELL CYCLE; EPITHELIAL CELLS; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MAMMARY GLANDS, HUMAN; PROGESTERONE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 4344707522     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:JOMG.0000023584.01750.16     Document Type: Review

References (70)

1. R. L. Sutherland and E. A. Musgrove (2004). Cyclins and breast cancer. J. Mammary Gland Biol. Neoplasia.
2. B. A. Howard and B. A. Gusterson (2000). Human breast development. J. Mammary Gland Biol. Neoplasia 5:119-137.
3. B. A. Gusterson, P. Monaghan, R. Mahendran, J. Ellis, and M. J. O'Hare (1986). Identification of myoepithelial cells in human and rat breasts by anti-common acute lymphoblastic leukemia antigen antibody A12. J. Natl. Cancer Inst. 77:343-349.
4. J. Taylor-Papadimitriou, R. Millis, J. Burchell, R. Nash, L. Pang, and J. Gilbert (1986). Patterns of reaction of monoclonal antibodies HMFG-1 and -2 with benign breast tissues and breast carcinomas. J. Exp. Pathol. 2:247-60.
5. J. Taylor-Papadimitriou, M. Stampfer, J. Bartek, A. Lewis, M. Boshell, E. B. Lane, et al. (1989). Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: Relation to in vivo phenotypes and influence of medium. J. Cell Sci. 94(Pt. 3):403-413.
6. J. T. Emerman, J. Stingl, A. Petersen, E. J. Shpall, and C. J. Eaves (1996). Selective growth of freshly isolated human breast epithelial cells cultured at low concentrations in the presence or absence of bone marrow cells. Breast Cancer Res. Treat. 41:147-159.
7. U. Latza, G. Niedobitek, R. Schwarting, H. Nekarda, and H. Stein (1990). Ber-EP4: New monoclonal antibody which distinguishes epithelia from mesothelial. J. Clin. Pathol. 43:213-219.
8. K. Joshi, J. A. Smith, N. Perusinghe, and P. Monoghan (1986). Cell proliferation in the human mammary epithelium. Differential contribution by epithelial and myoepithelial cells. Am. J. Pathol. 124:199-206.
9. O. W. Petersen, P. E. Hoyer, and B. van Deurs (1987). Frequency and distribution of estrogen receptor-positive cells in normal, nonlactating human breast tissue. Cancer Res. 47:5748-5751.
10. S. R. Wellings, H. M. Jensen, and R. G. Marcum (1975). An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J. Natl. Cancer Inst. 55:231-273.
11. C. W. Daniel and G. B. Silberstein (1987). Postnatal development of the rodent mammary gland. In M. C. Neville and C. W. Daniel (eds.), The Mammary Gland. Development, Regulation and Function, Plenum, New York, pp. 3-36.
12. J. Russo and I. H. Russo, (1987). Development of the human mammary gland. In M. C. Neville and C. W. Daniel (eds.), The Mammary Gland. Development, Regulation and Function, Plenum, New York, pp. 67-93.
13. M. M. Richert, K. L. Schwertfeger, J. W. Ryder, and S. M. Anderson (2000). An atlas of mouse mammary gland development. J. Mammary Gland Biol. Neoplasia 5:227-241.
14. H. McGregor, C. E. Land, K. Choi, S. Tokuoka, P. I. Liu, T. Wakabayashi, et al. (1977). Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki, 1950-69. J. Natl. Cancer Inst. 59:799-811.
15. M. Clemons and P. Goss (2001). Estrogen and the risk of breast cancer. N. Engl. J. Med. 344:276-285.
16. R. C. Travis and T. J. Key (2003). Oestrogen exposure and breast cancer risk. Breast Cancer Res. 5:239-247.
17. Z. Laron, R. Pauli, and A. Pertzelan (1989). Clinical evidence on the role of estrogens in the development of the breasts. Proc. R. Soc. Edinb. B1 95:13-22.
18. B. Fisher, J. P. Costantino, D. L. Wickerham, C. K. Redmond, M. Kavanah, W. M. Cronin, et al. (1998). Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J. Natl. Cancer Inst. 90:1371-1388.
19. W. P. Bocchinfuso and K. S. Korach (1997). Mammary gland development and tumorigenesis in estrogen receptor knockout mice. J. Mammary Gland Biol. Neoplasia 2:323-334.
20. R. A. Lubet, V. E. Steele, R. DeCoster, C. Bowden, M. You, M. M. Juliana, et al. (1998). Chemopreventive effects of the aromatase inhibitor vorozole (R 83842) in the methylnitrosourea-induced mammary cancer model. Carcinogenesis 19:1345-1351.
21. S. Nandi, R. C. Guzman, and J. Yang (1995). Hormones and mammary carcinogenesis in mice, rats, and humans: A unifying hypothesis. Proc. Natl. Acad. Sci. U.S.A. 92:3650-3657.
22. R. C. Humphreys, J. P. Lydon, B. W. O'Malley, and J. M. Rosen (1997). Use of PRKO mice to study the role of progesterone in mammary gland development. J. Mammary Gland Biol. Neoplasia 2:343-354.
23. V. Beral (2003). Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362:419-427.
24. R. K. Ross, A. Paganini-Hill, P. C. Wan, and M. C. Pike (2000). Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin. J. Natl. Cancer Inst. 92:328-332.
25. C. Schairer, J. Lubin, R. Troisi, S. Sturgeon, L. Brinton, and R. Hoover (2000). Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA 283:485-491.
26. E. Enmark, M. Pelto-Huikko, K. Grandien, S. Lagercrantz, J. Lagercrantz, G. Fried, et al. (1997). Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J. Clin. Endocrinol. Metab. 82:4258-4265.
27. V. Kumar, S. Green, G. Stack, M. Berry, J. R. Jin, and P. Chambon (1987). Functional domains of the human estrogen receptor. Cell 51:941-951.
28. J. M. Hall and D. P. McDonnell (1999). The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 140:5566-5578.
29. C. L. Clarke and R. L. Sutherland (1990). Progestin regulation of cellular proliferation. Endocr. Rev. 11:266-301.
30. E. Vegeto, M. M. Shahbaz, D. X. Wen, M. E. Goldman, B. W. O'Malley, and D. P. McDonnell (1993). Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Mol. Endocrinol. 7:1244-1255.
31. J. K. Richer, B. M. Jacobsen, N. G. Manning, M. G. Abel, D. M. Wolf, and K. B. Horwitz (2002). Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J. Biol. Chem. 277:5209-5218.
32. B. Mulac-Jericevic, J. P. Lydon, F. J. DeMayo, and O. M. Conneely (2003). Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proc. Natl. Acad. Sci. U.S.A. 100:9744-9749.
33. S. Ali and R. C. Coombes (2002). Endocrine-responsive breast cancer and strategies for combating resistance. Nat. Rev. Cancer 2:101-112.
34. D. P. McDonnell and J. D. Norris (2002). Connections and regulation of the human estrogen receptor. Science 296:1642-1644.
35. K. Vermeulen, D. R. Van Bockstaele, and Z. N. Berneman (2003). The cell cycle: A review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif. 36:131-149.
36. T. Evans, E. T. Rosenthal, J. Youngblom, D. Distel, and T. C. Hunt (1983). Cyclin: A protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division. Cell 33:389-396.
37. J. C. Pines (1991). Cyclins: Wheels within wheels. Cell Growth Differ. 2:305-310.
38. C. J. Sherr (1994). G1 phase progression: Cycling on cue. Cell 79:551-555.
39. M. Ohtsubo, A. M. Theodoras, J. Schumacher, J. M. Roberts, and M. Pagano (1995). Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol. Cell Biol. 15:2612-2624.
40. C. J. Sherr and J. M. Roberts (1999). CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev. 13:1501-1512.
41. S. F. Doisneau-Sixou, C. M. Sergio, J. S. Carroll, R. Hui, E. A. Musgrove, and R. L. Sutherland (2003). Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells. Endocr Relat Cancer 10:179-186.
42. R. B. Clarke, A. Howell, C. S. Potten, and E. Anderson (1997). Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res. 57:4987-4991.
43. G. Shyamala, Y. C. Chou, S. G. Louie, R. C. Guzman, G. H. Smith, and S. Nandi (2002). Cellular expression of estrogen and progesterone receptors in mammary glands: Regulation by hormones, development and aging. J. Steroid Biochem. Mol. Biol. 80:137-148.
44. V. Speirs, G. P. Skliris, S. E. Burdall, and P. J. Carder (2002). Distinct expression patterns of ER alpha and ER beta in normal human mammary gland. J. Clin. Pathol. 55:371-374.
45. J. F. Couse and K. S. Korach (1999). Estrogen receptor null mice: What have we learned and where will they lead us? Endocr. Rev. 20:358-417.
46. P. A. Mote, S. Bartow, N. Tran, and C. L. Clarke (2002). Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis. Breast Cancer Res. Treat. 72:163-172.
47. J. Russo, X. Ao, C. Grill, and I. H. Russo (1999). Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland. Breast Cancer Res. Treat. 53:217-227.
48. G. R. Cunha, P. Young, Y. K. Hom, P. S. Cooke, J. A. Taylor, and D. B. Lubahn (1997). Elucidation of a role for stromal steroid hormone receptors in mammary gland growth and development using tissue recombinants. J. Mammary Gland Biol. Neoplasia 2:393-402.
49. S. O. Mueller, J. A. Clark, P. H. Myers, and K. S. Korach (2002). Mammary gland development in adult mice requires epithelial and stromal estrogen receptor alpha. Endocrinology 143:2357-2365.
50. S. A. Bartow (1998). Use of the autopsy to study ontogeny and expression of the estrogen receptor gene in human breast. J. Mammary Gland Biol. Neoplasia 3:37-48.
51. C. Brisken, S. Park, T. Vass, J. P. Lydon, B. W. O'Malley, and R. A. Weinberg (1998). A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc. Natl. Acad. Sci. U.S.A. 95:5076-5081.
52. C. Brisken, A. Heineman, T. Chavarria, B. Elenbaas, J. Tan, S. K. Dey, et al. (2000). Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev. 14:650-654.
53. K. C. Chan, W. F. Knox, J. M. Gee, J. Morris, R. I. Nicholson, C. S. Potten, et al. (2002). Effect of epidermal growth factor receptor tyrosine kinase inhibition on epithelial proliferation in normal and premalignant breast. Cancer Res. 62:122-128.
54. T. J. Martin and M. T. Gillespie (2001). Receptor activator of nuclear factor kappa B ligand (RANKL): Another link between breast and bone. Trends. Endocrinol. Metab. 12:2-4.
55. E. A. Kritikou, A. Sharkey, K. Abell, P. J. Came, E. Anderson, R. W. Clarkson, et al. (2003). A dual, non-redundant, role for LIF as a regulator of development and STAT3-mediated cell death in mammary gland. Development 130:3459-3468.
56. R. C. Hovey, J. Harris, D. L. Hadsell, A. V. Lee, C. J. Ormandy, and B. K. Vonderhaar (2003). Local insulin-like growth factor-II mediates prolactin-induced mammary gland development. Mol. Endocrinol. 17:460-471.
57. C. Palmieri, D. Roberts-Clark, A. Assadi-Sabet, R. C. Coope, M. O'Hare, A. Sunters, et al. (2003). Fibroblast growth factor 7, secreted by breast fibroblasts, is an interleukin-1beta-induced paracrine growth factor for human breast cells. J. Endocrinol. 177:65-81.
58. D. C. Allred, S. K. Mohsin, and S. A. Fuqua (2001). Histological and biological evolution of human premalignant breast disease. Endocr. Relat. Cancer 8:47-61.
59. B. S. Shoker, C. Jarvis, D. R. Sibson, C. Walker, and J. P. Sloane (1999). Oestrogen receptor expression in the normal and pre-cancerous breast. J. Pathol. 188:237-244.
60. B. S. Shoker, C. Jarvis, R. B. Clarke, E. Anderson, J. Hewlett, M. P. Davies, et al. (1999). Estrogen receptor-positive proliferating cells in the normal and precancerous breast. Am. J. Pathol. 155:1811-1815.
61. E. Anderson, R. B. Clarke, and A. Howell (1998). Estrogen responsiveness and control of normal human breast proliferation. J. Mammary Gland Biol. Neoplasia 3:23-35.
62. V. Fantl, G. Stamp, A. Andrews, I. Rosewell, and C. Dickson (1995). Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev. 9:2364-2372.
63. Q. Yu, Y. Geng, and P. Sicinski (2001). Specific protection against breast cancers by cyclin D1 ablation. Nature 411:1017-1021.
64. T. C. Wang, R. D. Cardiff, L. Zukerberg, E. Lees, A. Arnold, and E. V. Schmidt (1994). Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369:669-671.
65. D. M. Barnes and C. E. Gillett (1998). Cyclin D1 in breast cancer. Breast Cancer Res. Treat 52:1-15.
66. X. L. Zhu , W. Hartwick, T. Rohan, and R. Kandel (1998). Cyclin D1 gene amplification and protein expression in benign breast disease and breast carcinoma. Mod. Pathol. 11:1082-1088.
67. B. S. Shoker, C. Jarvis, M. P. Davies, M. Iqbal, D. R. Sibson, and J. P. Sloane (2001). Immunodetectable cyclin D(1)is associated with oestrogen receptor but not Ki67 in normal, cancerous and precancerous breast lesions. Br. J. Cancer 84:1064-1069.
68. M. D. Planas-Silva, J. L. Donaher, and R. A. Weinberg (1999). Functional activity of ectopically expressed estrogen receptor is not sufficient for estrogen-mediated cyclin D1 expression. Cancer Res. 59:4788-4792.
69. D. A. Zajchowski, R. Sager, and L. Webster (1993). Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor. Cancer Res. 53:5004-5011.
70. M. H. Barcellos-Hoff (2003). Transforming growth factor beta's role in mammary gland development and carcinogenesis. Breast Cancer Res. 5(Suppl. 1):33.